Suchergebnisse - "Cismas, Sonia"

PubPharm (8)

1

Natural killer cells drive 4-1BBL positive uveal melanoma towards EMT and metastatic disease

enthalten in: Journal of experimental & clinical cancer research : CR | 2024

von Neo, S. | Oliveira, M. | Tong, L. | +12

2

Natural killer cells drive 4-1BBL positive uveal melanoma towards EMT and metastatic disease

enthalten in: Journal of experimental & clinical cancer research | 2024

von Neo, S. | Oliveira, M. | Tong, L. | +12

3

Competing Engagement of β-arrestin Isoforms Balances IGF1R/p53 Signaling and Controls Melanoma Cell Chemotherapeutic Responsiveness

enthalten in: Molecular cancer research : MCR | 2023

von Cismas, S. | Pasca, S. | Crudden, C. | +11

4

Correction : IGF-1R is a molecular determinant for response to p53 reactivation therapy in conjunctival melanoma

enthalten in: Oncogene | 2023

von Song, D. | Cismas, S. | Crudden, C. | +8

ErratumFor: Oncogene. 2022 Jan;41(4):600-611. - PMID 34785779

5

IGF-1R is a molecular determinant for response to p53 reactivation therapy in conjunctival melanoma

enthalten in: Oncogene | 2022

von Song, D. | Cismas, S. | Crudden, C. | +8

ErratumIn: Oncogene. 2023 Mar;42(11):858. - PMID 36759575

6

Inhibition of G Protein-Coupled Receptor Kinase 2 Promotes Unbiased Downregulation of IGF1 Receptor and Restrains Malignant Cell Growth

enthalten in: Cancer research | 2021

von Crudden, C. | Shibano, T. | Song, D. | +9

7

Below the Surface : IGF-1R Therapeutic Targeting and Its Endocytic Journey

enthalten in: Cells | 2019

von Crudden, C. | Song, D. | Cismas, S. | +5

8

Minimal residual disease in chronic lymphocytic leukemia : A consensus paper that presents the clinical impact of the presently available laboratory approaches

enthalten in: Critical reviews in clinical laboratory sciences | 2018

von Tomuleasa, C. | Selicean, C. | Cismas, S. | +17

1
[1]